Home » Authors » Nuala Moran

Articles by Nuala Moran

Celltech On Hunt For Partner Following Phase III Trial In RA

April 1, 2004

Celltech On Hunt For Partner Following Phase III Trial In RA

April 1, 2004

Arakis Acquires Sirus, Gains Access To Sublingual Platform

March 31, 2004

Vernalis Paying $50M To Regain Frovatriptan Rights From Elan

March 31, 2004

UK Awards Grants For Work Focused On Disease Genetics

March 31, 2004

Vernalis Paying $50M To Regain Frovatriptan Rights From Elan

March 31, 2004

Arakis Acquires Sirus, Gains Access To Sublingual Platform

March 31, 2004

UK Awards Grants For Work Focused On Disease Genetics

March 31, 2004

Celltech Considering Partners For CDP 870 Co-Development

March 24, 2004

Heeding Recommendation, UK Starts Clinical Trials Network

March 24, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...